Sawgrass Asset Management LLC Amgen Inc Transaction History

Sawgrass Asset Management LLC

$920 Million
Q2 2024

A detailed history of Sawgrass Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 36,943 shares of AMGN stock, worth $11.8 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

36,943

Previous 37,258 0.85%

Holding current value

$11.8 Million

Previous $10.6 Million 8.96%

% of portfolio

1.25%

Previous 1.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $82,766 - $100,582	-315 Reduced 0.85%	36,943 $11.5 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $5.28 Million - $6.37 Million	-19,633 Reduced 34.51%	37,258 $10.6 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $872,704 - $984,513	-3,413 Reduced 5.66%	56,891 $16.4 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $614,843 - $763,345	-2,812 Reduced 4.46%	60,304 $16.2 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $900,576 - $1.06 Million	-4,203 Reduced 6.24%	63,116 $14 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $460,385 - $561,132	-2,039 Reduced 2.94%	67,319 $16.3 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $170,856 - $217,093	-746 Reduced 1.06%	69,358 $18.2 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $603,348 - $680,467	-2,688 Reduced 3.69%	70,104 $15.8 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $1.19 Million - $1.32 Million	-5,154 Reduced 6.61%	72,792 $17.7 Million
Q1 2022 May 18, 2022	BUY	$219.27 - $242.57 $17.1 Million - $18.9 Million	77,946 New	77,946 $18.8 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $17.6 Million - $20.2 Million	-88,659 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $3.14 Million - $3.68 Million	-14,782 Reduced 14.29%	88,659 $18.9 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $8.26 Million - $9.16 Million	-35,364 Reduced 25.48%	103,441 $25.2 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $4.93 Million - $5.75 Million	-22,235 Reduced 13.81%	138,805 $34.5 Million
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $743,698 - $885,611	-3,437 Reduced 2.09%	161,040 $37 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $6.16 Million - $6.85 Million	-26,262 Reduced 13.77%	164,477 $41.8 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $17.3 Million - $21.3 Million	87,660 Added 85.04%	190,739 $45 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $17.9 Million - $23.8 Million	-98,405 Reduced 48.84%	103,079 $20.9 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $413,613 - $531,635	-2,186 Reduced 1.07%	201,484 $48.6 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $22.6 Million - $27.1 Million	-129,967 Reduced 38.95%	203,670 $39.4 Million
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $1.04 Million - $1.21 Million	-6,209 Reduced 1.83%	333,637 $61.5 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $1.38 Million - $1.55 Million	7,627 Added 2.3%	339,846 $64.6 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $6.31 Million - $7.36 Million	35,360 Added 11.91%	332,219 $64.7 Million
Q3 2018 Nov 19, 2018	BUY	$185.29 - $208.89 $53.6 Million - $60.4 Million	289,086 Added 3719.1%	296,859 $61.5 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $33.2 Million - $37.3 Million	-200,000 Reduced 96.26%	7,773 $38.4 Million
Q2 2018 Jul 26, 2018	BUY	$166.05 - $186.51 $14.2 Million - $15.9 Million	85,443 Added 69.85%	207,773 $38.4 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $719,230 - $840,510	-4,245 Reduced 3.35%	122,330 $20.9 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $5.64 Million - $6.3 Million	33,410 Added 35.86%	126,575 $22 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $15.3 Million - $17.5 Million	91,455 Added 5348.25%	93,165 $17.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,710	1,710 $295,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Account

Sawgrass Asset Management LLC Amgen Inc Transaction History